Papers/PMID:39683570
Curcumin Attenuates Hyperglycemia and Inflammation in Type 2 Diabetes Mellitus: Quantitative Analysis of Randomized Controlled Trial.
Nutrients2024The record
2 findings · 1 compound · 2 endpoints
What it reported
How to read these marksWhat moved
2 findings
curcumin — decreases C-reactive protein concentration
LikelyGrade B, Likely. Human evidence with one recorded weakness, or capped at B by its design or by unread numbers.Findingreplicated ×4“The overall effect estimates from the meta-analysis demonstrated a significant reduction in CRP in curcumin compared to placebo, SMD = −0.59, 95%CI (−1.11, −0.07), p = 0.03.”
Quoted verbatim from Curcumin Attenuates Hyperglycemia and Inflammation in Type 2 Diabetes Mellitus: Quantitative Analysis of Randomized Controlled Trial.. - Study
- meta-analysis
- Population
- adults with type 2 diabetes
Effect -0.59 standardised mean difference, 95% CI -1.11 to -0.07
Curcumin Attenuates Hyperglycemia and Inflammation in Type 2 Diabetes Mellitus: Quantitative Analysis of Randomized Controlled Trial.2024PMID:39683570Permalink
curcumin — decreases fasting blood glucose
LikelyGrade B, Likely. Human evidence with one recorded weakness, or capped at B by its design or by unread numbers.Findingreplicated ×4“The overall evidence showed a statistically significant reduction in FBG in the T2D group from curcumin compared to placebo MD = −11.48 mg/dL, 95%CI (−14.26, −8.70), p < 0.01.”
Quoted verbatim from Curcumin Attenuates Hyperglycemia and Inflammation in Type 2 Diabetes Mellitus: Quantitative Analysis of Randomized Controlled Trial.. - Study
- meta-analysis
- Population
- adults with type 2 diabetes
Effect -11.48 mean difference, 95% CI -14.26 to -8.7
Curcumin Attenuates Hyperglycemia and Inflammation in Type 2 Diabetes Mellitus: Quantitative Analysis of Randomized Controlled Trial.2024PMID:39683570Permalink